Familial warfarin resistance

R. J. Holt, C. O. Freytes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Warfarin, a coumarin anticoagulant, acts by interfering with the hepatic synthesis of the vitamin-K-dependent clotting factors. It is used clinically in the treatment or prophylaxis of venous thrombosis and embolisms. Resistance to the effects of the coumarin and indanedione anticoagulants has been reported in rats and man, but its incidence has been defined as extremely rare. Resistance has been described as relative, acquired, or hereditary. The first well-documented case was also the first report to identify a genetic basis for this resistance. Since that time, there has been only one other study that strengthened the evidence for a hereditary transmission, and only a few other reports have suggested hereditary influence as a reason for coumarin resistance. In this report, a patient who presented with a familial-type warfarin resistance is described. A discussion of previous reports and possible mechanisms for nonfamilial warfarin resistance is also included.

Original languageEnglish (US)
Pages (from-to)281-283
Number of pages3
JournalDrug Intelligence and Clinical Pharmacy
Volume17
Issue number4
StatePublished - 1983
Externally publishedYes

Fingerprint

Anticoagulants
Blood Coagulation Factors
Vitamin K
Warfarin
Embolism
Venous Thrombosis
Liver
Incidence
Coumarin Resistance
coumarin
Therapeutics
1,2-indanedione

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Holt, R. J., & Freytes, C. O. (1983). Familial warfarin resistance. Drug Intelligence and Clinical Pharmacy, 17(4), 281-283.

Familial warfarin resistance. / Holt, R. J.; Freytes, C. O.

In: Drug Intelligence and Clinical Pharmacy, Vol. 17, No. 4, 1983, p. 281-283.

Research output: Contribution to journalArticle

Holt, RJ & Freytes, CO 1983, 'Familial warfarin resistance', Drug Intelligence and Clinical Pharmacy, vol. 17, no. 4, pp. 281-283.
Holt, R. J. ; Freytes, C. O. / Familial warfarin resistance. In: Drug Intelligence and Clinical Pharmacy. 1983 ; Vol. 17, No. 4. pp. 281-283.
@article{d8e2c07270414251857a2b8b3fa13c6a,
title = "Familial warfarin resistance",
abstract = "Warfarin, a coumarin anticoagulant, acts by interfering with the hepatic synthesis of the vitamin-K-dependent clotting factors. It is used clinically in the treatment or prophylaxis of venous thrombosis and embolisms. Resistance to the effects of the coumarin and indanedione anticoagulants has been reported in rats and man, but its incidence has been defined as extremely rare. Resistance has been described as relative, acquired, or hereditary. The first well-documented case was also the first report to identify a genetic basis for this resistance. Since that time, there has been only one other study that strengthened the evidence for a hereditary transmission, and only a few other reports have suggested hereditary influence as a reason for coumarin resistance. In this report, a patient who presented with a familial-type warfarin resistance is described. A discussion of previous reports and possible mechanisms for nonfamilial warfarin resistance is also included.",
author = "Holt, {R. J.} and Freytes, {C. O.}",
year = "1983",
language = "English (US)",
volume = "17",
pages = "281--283",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "4",

}

TY - JOUR

T1 - Familial warfarin resistance

AU - Holt, R. J.

AU - Freytes, C. O.

PY - 1983

Y1 - 1983

N2 - Warfarin, a coumarin anticoagulant, acts by interfering with the hepatic synthesis of the vitamin-K-dependent clotting factors. It is used clinically in the treatment or prophylaxis of venous thrombosis and embolisms. Resistance to the effects of the coumarin and indanedione anticoagulants has been reported in rats and man, but its incidence has been defined as extremely rare. Resistance has been described as relative, acquired, or hereditary. The first well-documented case was also the first report to identify a genetic basis for this resistance. Since that time, there has been only one other study that strengthened the evidence for a hereditary transmission, and only a few other reports have suggested hereditary influence as a reason for coumarin resistance. In this report, a patient who presented with a familial-type warfarin resistance is described. A discussion of previous reports and possible mechanisms for nonfamilial warfarin resistance is also included.

AB - Warfarin, a coumarin anticoagulant, acts by interfering with the hepatic synthesis of the vitamin-K-dependent clotting factors. It is used clinically in the treatment or prophylaxis of venous thrombosis and embolisms. Resistance to the effects of the coumarin and indanedione anticoagulants has been reported in rats and man, but its incidence has been defined as extremely rare. Resistance has been described as relative, acquired, or hereditary. The first well-documented case was also the first report to identify a genetic basis for this resistance. Since that time, there has been only one other study that strengthened the evidence for a hereditary transmission, and only a few other reports have suggested hereditary influence as a reason for coumarin resistance. In this report, a patient who presented with a familial-type warfarin resistance is described. A discussion of previous reports and possible mechanisms for nonfamilial warfarin resistance is also included.

UR - http://www.scopus.com/inward/record.url?scp=0020584625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020584625&partnerID=8YFLogxK

M3 - Article

C2 - 6839959

AN - SCOPUS:0020584625

VL - 17

SP - 281

EP - 283

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 4

ER -